+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of survivin on cell proliferation and apoptosis in gastric cancer



Effect of survivin on cell proliferation and apoptosis in gastric cancer



Oncology Reports 9(6): 1213-1218



We investigated the effect of expression of survivin, an apoptosis inhibiting protein, on cellular proliferation and apoptosis in gastric cancer and assessed its relation to the pathological characteristics of gastric cancer. Resected gastric cancer specimens from 42 patients (intestinal type; 21 cases and diffuse type; 21 cases) were evaluated. There were no significant differences in the clinicopathologic factors between the two groups. Survivin mRNA expression was measured using real-time reverse transcription-polymerase chain reaction, and survivin protein expression was evaluated by immunohistochemical staining. The Ki-67 index was adopted for cell proliferation scoring, and the ss-DNA positive rate as an apoptotic index. The survivin mRNA expression inversely correlated with the apoptotic index (p<0.05). Survivin mRNA expression (p<0.001) and survivin protein expression (p<0.001) were significantly higher in the diffuse type than the intestinal type. In conclusion, gastric cancer avoids cellular death by survivin expression and this tendency was more conspicuous in diffuse type gastric cancer.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 010536456

Download citation: RISBibTeXText

PMID: 12375022


Related references

Effect of survivin targeting on cell proliferation and apoptosis in pancreatic cancer cells. Zhonghua Yi Xue Za Zhi 84(22): 1894-1898, 2004

Rapamycin inhibits the proliferation and apoptosis of gastric cancer cells by down regulating the expression of survivin. Hepato-Gastroenterology 58(107-108): 1075-1080, 2011

Effect of miR-340 on gastric cancer cell proliferation and apoptosis. International Journal of Clinical and Experimental Pathology 8(10): 13108-13113, 2015

Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Laboratory Investigation; a Journal of Technical Methods and Pathology 79(11): 1327-1333, 1999

Depression of MAD2 inhibits apoptosis and increases proliferation and multidrug resistance in gastric cancer cells by regulating the activation of phosphorylated survivin. Tumour Biology 31(3): 225-232, 2010

Effect of antisense miR-224 on gastric cancer cell proliferation and apoptosis. Zhonghua Zhong Liu Za Zhi 36(2): 92-96, 2014

Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World Journal of Gastroenterology 10(1): 22-25, 2004

Effects of shRNA-silenced livin and survivin on lung cancer cell proliferation and apoptosis. Journal of BUON 19(3): 757-762, 2014

Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer 107(4): 746-756, 2006

Effect of a selective COX-2 inhibitor on cell proliferation and apoptosis in human gastric cancer cell line BGC-823. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 33(12): 1123-1128, 2008

RUNX3 inhibits survivin expression and induces cell apoptosis in gastric cancer. European Journal of Cell Biology 93(3): 118-126, 2014

MiR‑203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. Molecular Medicine Reports 8(2): 379-384, 2013

Effect of parthenolide on proliferation and apoptosis in gastric cancer cell line SGC7901. Journal of Digestive Diseases 10(3): 172-180, 2009

Effect of liposomal transfection of survivin siRNA on proliferation and apoptosis of A549 cell. 2008

The suppression effect of Ferula gummosa Boiss extracts on cell proliferation through apoptosis induction in gastric cancer cell line. European Journal of Integrative Medicine 5(3): 241-247, 2013